Bridgeway Capital Management’s Allena Pharmaceuticals ALNA Stock Holding History

Bridgeway Capital Management’s Portfolio ALNA Stock Details ALNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-124,200	Closed	-$29K	–	1403
2022 Q1	$29K	Hold	124,200	–	–	﹤0.01%	1302
2021 Q4	$74K	Sell	124,200 -111,800	-47%	-$87.4K	﹤0.01%	1231
2021 Q3	$213K	Sell	236,000 -115,000	-33%	-$113K	﹤0.01%	1196
2021 Q2	$456K	Sell	351,000 -30,200	-8%	-$36.6K	0.01%	1090
2021 Q1	$530K	Buy	381,200 +222,400	+140%	+$371K	0.01%	1073
2020 Q4	$203K	Sell	158,800 -2,200	-1%	-$3.07K	﹤0.01%	1205
2020 Q3	$238K	Hold	161,000	–	–	0.01%	1142
2020 Q2	$254K	Hold	161,000	–	–	0.01%	1086
2020 Q1	$155K	Hold	161,000	–	–	﹤0.01%	1120
2019 Q4	$440K	Buy	161,000 +97,800	+155%	+$321K	0.01%	1033
2019 Q3	$249K	Hold	63,200	–	–	﹤0.01%	1138
2019 Q2	$257K	Sell	63,200 -20,000	-24%	-$109K	﹤0.01%	1132
2019 Q1	$584K	Hold	83,200	–	–	0.01%	984
2018 Q4	$453K	Hold	83,200	–	–	0.01%	1026
2018 Q3	$894K	Buy	83,200 +2,200	+3%	+$24.2K	0.01%	928
2018 Q2	$1.05M	Buy	81,000 +20,000	+33%	+$288K	0.01%	864
2018 Q1	$672K	Buy	+61,000	New	+$509K	0.01%	998

Other funds holding ALNA

TGI

TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

Bridgeway Capital Management's ALNA Position: Q2 2022 in Review

Bridgeway Capital Management sold out of Allena Pharmaceuticals (ALNA) in Q2 2022, closing a stake of 124,200 shares — an estimated $29K sold.

Bridgeway Capital Management first reported a position in ALNA in Q1 2018 and held it in 17 quarters. The position peaked at $1.05M in Q2 2018. 25 funds tracked by Wall St. Rank hold ALNA as of Q2 2022.

Bridgeway Capital Management reported no remaining Allena Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
Bridgeway Capital Management sold 124,200 Allena Pharmaceuticals shares in Q2 2022, an estimated $29K.
Bridgeway Capital Management first reported a position in Allena Pharmaceuticals in Q1 2018 and held it in 17 quarters.
Bridgeway Capital Management's Allena Pharmaceuticals position peaked at $1.05M in Q2 2018.
25 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q2 2022.

Based on Bridgeway Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.